Literature DB >> 8613923

The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344.

M A Oriowo1, H Chapman, D M Kirkham, M V Sennitt, R R Ruffolo, M A Cawthorne.   

Abstract

The stimulation by BRL 37344 of lipolysis in rat adipose tissues, and of relaxation of the rat distal colon, is mediated by the beta-3 adrenoceptor. The stereochemical requirements of the beta-3 adrenoceptor are poorly understood. The activities of the four stereoisomers of BRL 37344 (i.e., two pairs of diastereoisomers) on three beta-3 adrenoceptor-mediated responses (brown and white adipose tissue lipolysis and relaxation of distal colon) have been determined and compared with those responses mediated by beta-1 adrenoceptors (increase in atrial rate) and beta-2 adrenoceptors (uterine relaxation). The potency order for the stereoisomers (RR>RS=SR>>SS) was the same for all tissues, regardless of whether the response was mediated by beta-1, beta-2 or beta-3 adrenoceptors. These results indicate that both chiral centers are determinants of agonist potency at all three subtypes of the beta adrenoceptor. Furthermore, agonist activity at beta-1, beta-2 and beta-3 adrenoceptors resides predominantly with the RR enantiomer. Finally, the RR enantiomer of BRL 37344 was a more potent agonist in brown adipocytes (EC50 = 3.3 +/- 0.8 nM) than in white adipocytes (EC50 = 5.7 +/- 0.9 nM) or colon (EC50 = 27.5 +/- 7.7 nM).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613923

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.

Authors:  Gianfranco Alpini; Antonio Franchitto; Sharon Demorrow; Paolo Onori; Eugenio Gaudio; Candace Wise; Heather Francis; Julie Venter; Shelley Kopriva; Romina Mancinelli; Guido Carpino; Franco Stagnitti; Yoshiyuki Ueno; Yuyan Han; Fanyin Meng; Shannon Glaser
Journal:  Hepatology       Date:  2011-01-03       Impact factor: 17.425

Review 2.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

3.  Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.

Authors:  Y Igawa; Y Yamazaki; H Takeda; K Hayakawa; M Akahane; Y Ajisawa; T Yoneyama; O Nishizawa; K E Andersson
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Effect of β3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors.

Authors:  T R Butler; A M Chappell; J L Weiner
Journal:  Psychopharmacology (Berl)       Date:  2013-08-17       Impact factor: 4.530

5.  beta-Adrenergic receptor stimulation of L-type Ca2+ channels in rabbit portal vein myocytes involves both alphas and betagamma G protein subunits.

Authors:  J Zhong; J R Hume; K D Keef
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

6.  Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.

Authors:  Yuval Silberman; Olusegun J Ariwodola; Ann M Chappell; Jordan T Yorgason; Jeff L Weiner
Journal:  Neuropsychopharmacology       Date:  2010-04-21       Impact factor: 7.853

7.  Modulation of musculoskeletal hyperalgesia by brown adipose tissue activity in mice.

Authors:  Elizabeth M Goudie-DeAngelis; Ramy E Abdelhamid; Myra G Nunez; Casey L Kissel; Katalin J Kovács; Philip S Portoghese; Alice A Larson
Journal:  Pain       Date:  2016-11       Impact factor: 7.926

8.  Pharmacophore-guided Virtual Screening to Identify New β3 -adrenergic Receptor Agonists.

Authors:  Navista Sri Octa Ujiantari; Seungmin Ham; Chisae Nagiri; Wataru Shihoya; Osamu Nureki; Dana Sabine Hutchinson; Daniela Schuster
Journal:  Mol Inform       Date:  2022-02-02       Impact factor: 4.050

9.  Cardioprotective and β-adrenoceptor antagonistic activity of a newly synthesized aryloxypropanolamine derivative PP-36.

Authors:  Lokesh K Bhatt; Jyotika Bansal; Poonam Piplani; S L Bodhankar; A Veeranjaneyulu
Journal:  J Exp Pharmacol       Date:  2010-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.